Brazilian Guidelines For The Management Of Candidiasis - A Joint Meeting Report Of Three Medical Societies: Sociedade Brasileira De Infectologia, Sociedade Paulista De Infectologia And Sociedade Brasileira De Medicina Tropical

dc.creatorColombo A.L.
dc.creatorGuimaraes T.
dc.creatorCamargo L.F.A.
dc.creatorRichtmann R.
dc.creatorde Queiroz-Telles F.
dc.creatorSalles M.J.C.
dc.creatorda Cunha C.A.
dc.creatorYasuda M.A.S.
dc.creatorMoretti M.L.
dc.creatorNucci M.
dc.date2013
dc.date2015-06-25T19:13:32Z
dc.date2015-11-26T15:11:02Z
dc.date2015-06-25T19:13:32Z
dc.date2015-11-26T15:11:02Z
dc.date.accessioned2018-03-28T22:21:07Z
dc.date.available2018-03-28T22:21:07Z
dc.identifierBrazilian Journal Of Infectious Diseases. , v. 17, n. 3, p. 283 - 312, 2013.
dc.identifier10.1016/j.bjid.2013.02.001
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84878415311&partnerID=40&md5=f0bba7a71910f3c0e498aa2ef901e0d1
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/88878
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/88878
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1258036
dc.descriptionCandida infections account for 80% of all fungal infections in the hospital environment, including bloodstream, urinary tract and surgical site infections. Bloodstream infections are now a major challenge for tertiary hospitals worldwide due to their high prevalence and mortality rates. The incidence of candidemia in tertiary public hospitals in Brazil is approximately 2.5 cases per 1000 hospital admissions. Due to the importance of this infection, the authors provide a review of the diversity of the genus Candida and its clinical relevance, the therapeutic options and discuss the treatment of major infections caused by Candida. Each topography is discussed with regard to epidemiological, clinical and laboratory diagnostic and therapeutic recommendations based on levels of evidence. © 2013 Elsevier Editora Ltda.
dc.description17
dc.description3
dc.description283
dc.description312
dc.descriptionColombo, A.L., Guimarães, T., Epidemiology of hematogenous infections due to Candida spp. (2003) Rev Soc Bras Med Trop, 36, pp. 599-607
dc.descriptionDignani, M.C., Solomkin, J.S., Anaissie, E., Candida (2003) Medical mycology. 1, pp. 195-239. , Churchill Livingstone, Filadélfia, E. Anaissie, M.R. McGinnis, M.A. Pfaller (Eds.)
dc.descriptionVanden Abbeele, A., de Meel, H., Ahariz, M., Perraudin, J.P., Beyer, I., Courtois, P., Denture contamination by yeasts in the elderly (2008) Gerodontology, 25, pp. 222-228
dc.descriptionJohnson, N.W., The mouth in HIV/AIDS: markers of disease status and management challenges for the dental profession (2010) Aust Dent J, 55 (SUPPL. 1), pp. 85-102
dc.descriptionKennedy, M.A., Sobel, J.D., Vulvovaginal candidiasis caused by non-albicans Candida species: new insights (2010) Curr Infect Dis Rep, 12, pp. 465-470
dc.descriptionAchkar, J.M., Fries, B.C., Candida infections of the genitourinary tract (2010) Clin Microbiol Rev, 23, pp. 253-273
dc.descriptionMorace, G., Borghi, E., Fungal infections in ICU patients: epidemiology and the role of diagnostics (2010) Minerva Anestesiol, 76, pp. 950-956
dc.descriptionWey, S.B., Mori, M., Pfaller, M.A., Woolson, R.F., Wenzel, R.P., Hospital acquired candidemia: the attributable mortality and excess length of stay (1988) Ann Intern Med, 148, pp. 2642-2645
dc.descriptionColombo, A.L., Nucci, M., Park, B.J., Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers (2006) J Clin Microbiol, 44, pp. 2816-2823
dc.descriptionBassetti, M., Trecarichi, E.M., Righi, E., Incidence, risk factors and predictors of outcome of candidemia: survey in 2 Italian university hospitals (2007) Diagn Microbiol Infect Dis, 58, pp. 325-331
dc.descriptionDiekema, D.J., Messer, S.A., Brueggemann, A.B., Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study (2002) J Clin Microbiol, 40, pp. 1298-1302
dc.descriptionThom, K., Forrest, G., Gastrointestinal infections in immunocompromised hosts (2006) Curr Opin Gastroenterol, 22, pp. 18-23
dc.descriptionPappas, P.G., Kauffman, C.A., Andes, D., Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America (2009) Clin Infect Dis, 48, pp. 503-535
dc.descriptionBarbaro, G., Barbarini, G., Di Lorenzo, G., Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study (1995) Scand J Infect Dis, 27, pp. 613-617
dc.descriptionQueiroz-Telles, F., Silva, N., Carvalho, M.M., Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients (2001) Braz J Infect Dis, 5, pp. 60-66
dc.descriptionAlly, R., Schurmann, D., Kreisel, W., A randomized, double blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients (2001) Clin Infect Dis, 33, pp. 1447-1454
dc.descriptionVasquez, J.A., Skiest, D.J., Nieto, L., A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS (2006) Clin Infect Dis, 42, pp. 1179-1186
dc.descriptionSkiest, D.J., Vazquez, J.A., Anstead, G.M., Posaconazole for the treatment of azole refractory oropharyngeal and esophageal candidiasis in subjects with HIV infections (2007) Clin Infect Dis, 44, pp. 607-614
dc.descriptionFinlay, P.M., Richardson, M.D., Robertson, A.G., A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours (1996) Br J Oral Maxillofac Surg, 34, pp. 23-25
dc.descriptionVillanueva, A., Gotuzzo, E., Arathoon, E.G., A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis (2002) Am J Med, 113, pp. 294-299
dc.descriptionKrause, D.S., Simjee, A.E., van Rensburg, C., A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis (2004) Clin Infect Dis, 39, pp. 770-775
dc.descriptionColombo, A.L., Guimarães, T., Candiduria: a clinical and therapeutic approach (2007) Rev Soc Bras Med Trop, 40, pp. 332-337
dc.descriptiondeWet, N., Llanos-Cuentas, A., Suleiman, J., A randomized, double blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV positive patients (2004) Clin Infect Dis, 39, pp. 842-849
dc.descriptionGiraldo, P., Witkin, S., Vaginal candidiasis: an incomprehensible challenge (1998) I Bras Dis Sex Transm, 10, pp. 31-36
dc.descriptionHolanda, A., Fernandes, A., Bezerra, C., Milan, E., Candidíase vulvovaginal: uma revisão de literatura (2005) Femina, 33, pp. 47-51
dc.descriptionNovawack, D., Lara, F., Estudo dos aspectos clínicos, epidemiológicos e atualização terapêutica das vulvovaginites por Candida sp, Trichomonas vaginalis e vaginoses bacterianas por Gardnerella vaginalis (1999) JBM, 77, pp. 46-50
dc.descriptionGalle, L., Gianinni, M., Prevalência e susceptibilidade de leveduras vaginais (2004) J Bras Patol Med Lab, 40, pp. 229-236
dc.descriptionSobel, J.D., Pathogenesis and treatment of recurrent vulvovaginal candidiasis (1992) Clin Infect Dis, 14, pp. S148-S153
dc.descriptionSobel, J.D., Vulvovaginal candidosis (2007) Lancet, 369, pp. 1961-1971
dc.descriptionCosta, M., Fernandes, O., Silva, M., Candidíase vulvovaginal: aspectos clínicos, tratamento oral com azólicos e suscetibilidade in vitro (2003) Rev Pat Trop, 32, pp. 145-162
dc.descriptionWatson, M.C., Grimshaw, J.M., Bond, C.M., Mollison, J., Ludbrook, A., Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review (2002) BJOG, 109, pp. 85-95
dc.descriptionUrunsak, M., Ilkit, M., Euruke, C., Urunsak, I., Clinical and mycological efficacy of single-day oral treatment with itraconazole (400mg) in acute vulvovaginal candidosis (2004) Mycoses, 47, pp. 422-427
dc.descriptionBennett, R.J., A Candida-based view of fungal sex and pathogenesis (2009) Genome Biol, 10, p. 230
dc.descriptionKimberly, A.W., Stuart, M.B., Sexually transmitted diseases treatment guidelines 2006 (2006) MMWR, 55, pp. 1-54
dc.descriptionSobel, J.D., Wiesenfeld, H.C., Martens, M., Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis (2004) N Engl J Med, 351, pp. 876-883
dc.descriptionFong, I.W., The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis (1992) Genitourin Med, 68, pp. 374-377
dc.descriptionWitt, A., Kaufmann, U., Bitschnau, M., Monthly itraconazole versus classic homeopathy for the treatment of recurrent vulvovaginal candidiasis: a randomised trial (2009) BJOG, 116, pp. 1499-1505
dc.descriptionRay, D., Goswami, R., Banerjee, U., Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis (2007) Diabetes Care, 30, pp. 312-317
dc.descriptionAlvarez-Lerma, F., Nolla-Salas, J., Leon, C., Candiduria in critically ill patients admitted to intensive care medical units (2003) Intensive Care Med, 29, pp. 1069-1076
dc.descriptionKauffman, C.A., Candiduria (2005) Clin Infect Dis, 41, pp. S371-S376
dc.descriptionSobel, J.D., Fisher, J.F., Kauffman, C.A., Newman, C.A., Candida urinary tract infections - epidemiology (2011) Clin Infect Dis, 52 (SUPPL. 6), pp. S433-S436
dc.descriptionNucci, M., Candiduria in hospitalized patients: a review (2000) Braz J Infect Dis, 4, pp. 168-172
dc.descriptionOliveira, R.D., Maffei, C.M., Martinez, R., Nosocomial urinary tract infections by Candida species (2001) Rev Assoc Med Bras, 47, pp. 231-235
dc.descriptionColeman, D.C., Rinaldi, M.G., Haynes, K.A., Importance of Candida species other than Candida albicans as opportunistic pathogens (1998) Med Mycol, 36 (SUPPL. 1), pp. 156-165
dc.descriptionKobayashi, C.C., De Fernandes, O.F., Miranda, K.C., De Sousa, E.D., Silva Mdo, R., Candiduria in hospital patients: a study prospective (2004) Mycopathologia, 158, pp. 49-52
dc.descriptionPassos, X.S., Sales, W.S., Maciel, P.J., Candida colonization in intensive care unit patients' urine (2005) Mem Inst Oswaldo Cruz, 100, pp. 925-928
dc.descriptionSobel, J.D., Controversies in the diagnosis of candiduria: what is the critical colony count (2002) Curr Treat Opt Infect Dis, 4, pp. 81-83
dc.descriptionFisher, J.F., Newman, C.L., Sobel, J.D., Yeasts in the urine: solutions for a budding problem (1995) Clin Infect Dis, 20, pp. 183-189
dc.descriptionAng, B.S.P., Telenti, A., King, B., Steckalberg, J.M., Wilson, W.D., Candidemia from urinary tract source: microbiological aspects and clinical significance (1993) Clin Infect Dis, 17, pp. 622-627
dc.descriptionLundstrom, T., Sobel, J., Nosocomial candiduria: a review (2001) Clin Infect Dis, 32, pp. 1602-1607
dc.descriptionSobel, J.D., Kauffman, C.A., McKinsey, D., Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo (2000) Clin Infect Dis, 30, pp. 19-24
dc.descriptionFan-Havard, P., O'Donovan, C., Smith, S.M., Oh, J., Bamberger, M., Eng, R.H.K., Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria (1995) Clin Infect Dis, 21, pp. 960-965
dc.descriptionFisher, J.F., Sobel, J.D., Kauffman, C.A., Newman, C.A., Candida urinary tract infections - treatment (2011) Clin Infect Dis, 52 (SUPPL. 6), pp. S457-S466
dc.descriptionJohnson, J.R., Should all catheterized patients with candiduria be treated? (1993) Clin Infect Dis, 17, p. 814
dc.descriptionTavanti, A., Davidson, A.D., Gow, N.A., Maiden, M.C., Odds, F.C., Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III (2005) J Clin Microbiol, 43, pp. 284-292
dc.descriptionBibashi, E., Memmos, D., Kokolina, E., Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases (2003) Clin Infect Dis, 36, pp. 927-931
dc.descriptionPowe, N.R., Septicemia in dialysis patients: incidence, risk factors and prognosis (1999) Kidney Int, 55, pp. 1081-1090
dc.descriptionChen, K.H., Chang, C.T., Yu, C.C., Candida parapsilosis peritonitis has more complications than other Candida peritonitis in peritoneal dialysis patients (2006) Ren Fail, 28, pp. 241-246
dc.descriptionWang, A.Y., Yu, A.W., Li, P.K., Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center (2000) Am J Kidney Dis, 36, pp. 1183-1192
dc.descriptionPrasad, N., Gupta, A., Fungal peritonitis in peritoneal dialysis patients (2005) Perit Dial Int, 25, pp. 207-222
dc.descriptionMatuszkiewicz-Rowinska, J., Update on fungal peritonitis and its treatment (2009) Perit Dial Int, 29 (SUPPL. 2), pp. S161-S165
dc.descriptionKameoka, H., Kumakawa, K., Matuoka, T., Nakano, M., Shiraiwa, Y., Yamaguchi, O., Intraperitoneal fluconazole for fungal peritonitis in CAPD: report of two cases (1999) Perit Dial Int, 19, pp. 481-483
dc.descriptionWong, P.N., Lo, K.Y., Tong, G.M., Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine and delayed catheter replacement in continuous ambulatory peritoneal dialysis (2008) Perit Dial Int, 28, pp. 155-162
dc.descriptionCornely, O.A., Lasso, M., Betts, R., Caspofungin for the treatment of less common forms of invasive candidiasis (2007) J Antimicrob Chemother, 60, pp. 363-369
dc.descriptionSandven, P., Qvist, H., Skovlund, E., Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations (2002) Crit Care Med, 30, pp. 541-547
dc.descriptionGonçalves, S.S., Amorim, C.S., Nucci, M., Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil (2010) Clin Microbiol Infect, 16, pp. 885-887
dc.descriptionCalandra, T., Bille, J., Schneider, R., Mosimann, F., Francioli, P., Clinical significance of Candida isolated from peritoneum in surgical patients (1989) Lancet, 2, pp. 1437-1440
dc.descriptionMontravers, P., Dupont, H., Gauzit, R., Candida as a risk factor for mortality in peritonitis (2006) Crit Care Med, 34, pp. 646-652
dc.descriptionSolomkin, J.S., Mazuski, J.E., Bradley, J.S., Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America (2010) Clin Infect Dis, 50, pp. 133-164
dc.descriptionStijn, I., Blota, B., Koenraad, H., Vandewoudea, B., Jan, J., Candida peritonitis (2007) Curr Opin Crit Care, 13, pp. 195-199
dc.descriptionAzoulay, E., Cohen, Y., Zahar, J.R., Practices in nonneutropenic ICU patients with Candida-positive airway specimens (2004) Intensive Care Med, 30, pp. 1384-1389
dc.descriptionNunley, D.R., Gal, A.A., Vega, J.D., Perlino, C., Smith, P., Lawrence, E.C., Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation (2002) Chest, 122, pp. 1185-1191
dc.descriptionEl-Ebiary, M., Torres, A., Fabregas, N., Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study (1997) Am J Respir Crit Care Med, 156, p. 583
dc.descriptionAlvarez-Lerma, F., Palomar, M., Leon, C., Fungal colonization and/or infection in intensive care units. Multicenter study of 1,562 patients (2003) Med Clin (Barc), 121, pp. 161-166
dc.descriptionKontoyiannis, D.P., Reddy, B.T., Torres, H.A., Pulmonary candidiasis in patients with cancer: an autopsy study (2002) Clin Infect Dis, 34, pp. 400-403
dc.descriptionFranquet, T., Muller, N.L., Lee, K.S., Oikonomou, A., Flint, J.D., Pulmonary candidiasis after hematopoietic stem cell transplantation: thin-section CT findings (2005) Radiology, 236, pp. 332-337
dc.descriptionHiller, E., Zavrel, M., Hauser, N., Adaptation, adhesion and invasion during interaction of Candida albicans with the host-focus on the function of cell wall proteins (2011) Int J Med Microbiol, 301, pp. 384-389
dc.descriptionOner-Eyuboglu, F., Karacan, O., Akcay, S., Arslan, H., Demirhan, B., Haberal, M., Invasive pulmonary fungal infections in solid organ transplant recipients: a four-year review (2003) Transplant Proc, 35, pp. 2689-2691
dc.descriptionYamada, H., Kotaki, H., Takahashi, T., Recommendations for the treatment of fungal pneumonias (2003) Expert Opin Pharmacother, 4, pp. 1241-1258
dc.descriptionCole, G.T., Halawa, A.A., Anaisse, E.J., The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. 73-88
dc.descriptionAlexander, J.W., Boyce, S.T., Babcock, G.F., The process of microbial translocation (1990) Ann Surg, 212, pp. 496-510
dc.descriptionLunel, F.M.V., Meis, J.F.G.M., Voss, A., Nosocomial fungal infections: candidemia (1999) Diagn Microbiol Infect Dis, 34, pp. 213-220
dc.descriptionWey, S.B., Mori, M., Pfaller, M.A., Woolson, R.F., Wenzel, R.P., Hospital acquired candidemia. The attributable mortality and excess length of stay (1988) Arch Intern Med, 148, pp. 2642-2645
dc.descriptionColombo, A.L., Perfect, J., DiNubile, M., Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis (2003) Eur J Clin Microbiol Infect Dis, 22, pp. 470-474
dc.descriptionPasqualotto, A.C., Zimerman, R.A., Alves, S.H., Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil (2008) Infect Control Hosp Epidemiol, 29, pp. 898-899
dc.descriptionDebusk, C.H., Daoud, R., Thirumoorthi, M.C., Wilson, F.M., Khatib, R., Candidemia: current epidemiologic characteristics and a long term follow-up of the survivors (1994) Scand J Infect Dis, 26, pp. 697-703
dc.descriptionKriengkauykiat, J., Ito, J.I., Dadwal, S.S., Epidemiology and treatment approaches in management of invasive fungal infections (2011) Clin Epidemiol, 3, pp. 175-191
dc.descriptionBen-Ami, R., Garcia-Effron, G., Lewis, R.E., Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance (2011) J Infect Dis, 204, pp. 626-635
dc.descriptionBodey, G.P., Luna, M., Skin lesions associated with disseminated candidiasis (1974) JAMA, 229, pp. 1466-1468
dc.descriptionRodriguez-Adrian, L.J., King, R.T., Tamayo-Derat, L.G., Miller, J.W., Garcia, C.A., Rex, J.H., Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology (2003) Medicine (Baltimore), 82, pp. 187-202
dc.descriptionOude Lashof, A.M., Rothova, A., Sobel, J.D., Ocular manifestations of candidemia (2011) Clin Infect Dis, 53, pp. 262-268
dc.descriptionKrishna, R., Amuh, D., Lowder, C.Y., Gordon, S.M., Adal, K.A., Hall, G., Should all patients with candidemia have an ophthalmic examination to rule out ocular candidiasis (2000) Eye, 14, pp. 30-34
dc.descriptionFiller, S.G., Kullberg, B.J., Deep-seated candidal infections (2003) Medical mycology, pp. 341-348. , Churchill Livingstone, Filadélfia, E. Anaissie, M.R. McGinnis, M.A. Pfaller (Eds.)
dc.descriptionDonnino, M.W., Goyal, N., Terlecki, T.M., Inadequate blood volume collected for culture: a survey of health care professionals (2007) Mayo Clin Proc, 82, pp. 1069-1072
dc.descriptionHorvath, L.L., George, B.J., Hospenthal, D.R., Detection of fifteen species of Candida in an automated blood culture system (2007) J Clin Microbiol, 45, pp. 3062-3064
dc.descriptionMasood, A., Sallah, S., Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment (2005) Leuk Res, 29, pp. 493-501
dc.descriptionAlmirante, B., Cuenca-Estrella, M., Candidemia: impact of epidemiological studies on the treatment and prognosis of a serious infection (2011) Enferm Infecc Microbiol Clin, 29, pp. 325-327
dc.descriptionMotta, A.L., Almeida, G.M., Almeida Júnior, J.N., Burattini, M.N., Rossi, F., Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex (2010) Braz J Infect Dis, 14, pp. 441-448
dc.descriptionSanglard, D., Odds, F.C., Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences (2002) Lancet Infect Dis, 2, pp. 73-85
dc.descriptionAndes, D.R., Safdar, N., Baddley, J.W., (2012), 54, pp. 1110-1122. , for the Mycoses Study Group. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect DisRex, J.H., Pappas, P.G., Karchmer, A.W., A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects (2003) Clin Infect Dis, 36, pp. 1221-1228
dc.descriptionBates, D.W., Su, L., Yu, D.T., Mortality and costs of acute renal failure ass
dc.descriptionSullivan, D., Coleman, D., Candida dubliniensis: characteristics and identification (1998) J Clin Microbiol, 36, pp. 329-334
dc.descriptionMariano, P.L., Milan, E.P., da Matta, D.A., Colombo, A.L., Candida dubliniensis identification in Brazilian yeast stock collection (2003) Mem Inst Oswaldo Cruz, 98, pp. 533-538
dc.descriptionKrcmery, V., Barnes, A.J., Non-albicans Candida spp. causing fungemia: pathogenicity and antifungal resistance (2002) J Hosp Infect, 50, pp. 243-260
dc.descriptionGodoy, P., Tiraboschi, I.N., Severo, L.C., Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals (2003) Mem Inst Oswaldo Cruz, 98, pp. 401-405
dc.descriptionPfaller, M.A., Nosocomial candidiasis: emerging species, reservoirs and modes of transmission (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. S89-S94
dc.descriptionColombo, A.L., Guimarães, T., Silva, L.R., Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality (2007) Infect Control Hosp Epidemiol, 28, pp. 570-576
dc.descriptionCosta, S.F., Marinho, I., Araújo, E.A., Manrique, A.E., Medeiros, E.A.S., Levin, A.S., Nosocomial fungaemia: a 2-year prospective study (2000) J Hosp Infect, 45, pp. 69-72
dc.descriptionLevin, A.S., Costa, S.F., Mussi, N.S., Candida parapsilosis fungemia associated with implantable and semiimplantable central venous catheters and the hands of health care workers (1998) Diagn Microbiol Infect Dis, 30, pp. 243-249
dc.descriptionPfaller, M.A., Messer, S.A., Moet, G.J., Jones, R.N., Castanheira, M., Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENT RY Antimicrobial Surveillance Program (2008-2009) (2011) Int J Antimicrob Agents, 38, pp. 65-69
dc.descriptionPfaller, M.A., Diekema, D.J., Ostrosky-Zeichner, L., Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints (2008) J Clin Microbiol, 46, pp. 2620-2629
dc.descriptionMora-Duarte, J., Betts, R., Rotstein, C., Comparison of caspofungin and amphotericin B for invasive candidiasis (2002) N Engl J Med, 347, pp. 2020-2029
dc.descriptionKuse, E.R., Chetchotisakd, P., da Cunha, C.A., Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial (2007) Lancet, 369, pp. 1519-1527
dc.descriptionReboli, A.C., Rotstein, C., Pappas, P.G., Anidulafungin versus fluconazole for invasive candidiasis (2007) N Engl J Med, 356, pp. 2472-2482
dc.descriptionKofteridis, D.P., Lewis, R.E., Kontoyiannis, D.P., Caspofungin-nonsusceptible Candida isolates in cancer patients (2010) J Antimicrob Chemother, 65, pp. 293-295
dc.descriptionColombo, A.L., Ngai, A.L., Bourque, M., Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database (2010) Antimicrob Agents Chemother, 54, pp. 1864-1871
dc.descriptionKale-Pradhan, P.B., Morgan, G., Wilhelm, S.M., Johnson, L.B., Comparative efficacy of echinocandins and nonechinocandins for the treatment of Candida parapsilosis infections: a meta-analysis (2010) Pharmacotherapy, 30, pp. 1207-1213
dc.descriptionMelo, A.S., Bizerra, F.C., Freymüller, E., Arthington-Skaggs, B.A., Colombo, A.L., Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex (2011) Med Mycol, 49, pp. 253-262
dc.descriptionWingard, J.R., Importance of Candida species other than C. albicans as pathogens in oncology patients (1995) Clin Infect Dis, 20, pp. 115-125
dc.descriptionColombo, A.L., Nucci, M., Salomão, R., High rate of nonalbicans candidemia in Brazilian tertiary care hospitals (1999) Diagn Microbiol Infect Dis, 34, pp. 281-286
dc.descriptionGoldani, L.Z., Mario, P.S., Candida tropicalis fungemia in a tertiary care hospital (2003) J Infect, 46, pp. 150-160
dc.descriptionAlp, S., Sancak, B., Hascelik, G., Arikan, S., Influence of different susceptibility testing methods and media on determination of the relevant fluconazole minimum inhibitory concentrations for heavy trailing Candida isolates with low-high phenotype (2010) Mycoses, 53, pp. 475-480
dc.descriptionAbi-Said, D., Anaissie, E., Uzun, O., Pinzcowski, H., Vartivarian, S., The epidemiology of hematogenous candidiasis caused by different Candida species (1997) Clin Infect Dis, 24, pp. 1122-1128
dc.descriptionNucci, M., Queiroz-Telles, F., Tobón, A.M., Restrepo, A., Colombo, A.L., Epidemiology of opportunistic fungal infections in Latin America (2010) Clin Infect Dis, 51, pp. 561-570
dc.descriptionSampaio Camargo, T.Z., Marra, A.R., Silva, C.V., Secular trends of candidemia in a tertiary care hospital (2010) Am J Infect Control, 38, pp. 546-551
dc.descriptionPfaller, M.A., Diekema, D.J., Jones, R.N., International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole and voriconazole of isolates collected from 1997 through 1999 in the SENT RY antimicrobial surveillance program (2001) J Clin Microbiol, 39, pp. 3254-3259
dc.descriptionSafran, D.B., Dawson, E., The effect of empiric and prophylactic treatment with fluconazole on yeast isolates in a surgical trauma intensive care unit (1997) Arch Surg, 132, pp. 1184-1188
dc.descriptionPfaller, M.A., Messer, S.A., Boyken, L., Tendolkar, S., Hollis, R.J., Diekema, D.J., Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002 (2004) J Clin Microbiol, 42, pp. 3142-3146
dc.descriptionDiekema, D.J., Pfaller, M.A., Jones, R.N., Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America. SENT RY Antimicrobial Surveillance Program, 1997-2000 (2002) Int J Antimicrob Agents, 20, pp. 412-418
dc.descriptionIwen, P.C., Kelly, D.M., Reed, E.C., Hinrichs, S.H., Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole (1995) Clin Infect Dis, 20, pp. 342-347
dc.descriptionDrago, M., Scaltrito, M.M., Morace, G., In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei (2004) Eur J Clin Microbiol Infect Dis, 23, pp. 619-624
dc.descriptionGirmenia, C., Pizzarelli, G., Cristini, F., Candida guilliermondii fungemia in patients with hematologic malignancies (2006) J Clin Microbiol, 44, pp. 2458-2464
dc.descriptionHazen, K.C., New and emerging yeast pathogens (1995) Clin Microbiol Rev, 8, pp. 462-478
dc.descriptionMerz, W.G., Candida lusitaniae: frequency of recovery, colonization, infection and amphotericin B resistance (1984) J Clin Microbiol, 20, pp. 1194-1195
dc.descriptionHata, D.J., Hall, L., Fothergill, A.W., Larone, D.H., Wengenack, N.L., Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card (2007) J Clin Microbiol, 45, pp. 1087-1092
dc.descriptionForrest, G., Role of antifungal susceptibility testing in patient management (2006) Curr Opin Infect Dis, 19, pp. 538-543
dc.descriptionPerkhofer, S., Mrazek, C., Hartl, L., Lass-Flörl, C., In vitro susceptibility testing in fungi: what is its role in clinical practice? (2010) Curr Infect Dis Rep, 12, pp. 401-408
dc.descriptionTraeder, C., Kowoll, S., Arastéh, K., Candida infection in HIV positive patients 1985-2007 (2008) Mycoses, 51 (SUPPL. 2), pp. 58-61
dc.description(2008) Reference method for broth dilution antifungal susceptibility testing of yeasts. Document M27-A3, 28, pp. 1-7. , Clinical and Laboratory Standards Institute (CLSI)
dc.descriptionSubcommittee on Antifungal Susceptibility Testing (AFST) of the, ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts (2008) Clin Microbiol Infect, 14, pp. 398-405
dc.descriptionFarina, C., Manso, E., Andreoni, S., Interlaboratory evaluation of VITEK-2 system and Sensititre YeastOne® for antifungal susceptibility testing of yeasts isolated from blood cultures against four antifungal agents (2011) New Microbiol, 34, pp. 195-201
dc.descriptionCuenca-Estrella, M., Rodriguez-Tudela, J.L., The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro (2010) Expert Rev Anti Infect Ther, 8, pp. 267-276
dc.descriptionBaginski, M., Czub, J., Amphotericin B and its new derivatives - mode of action (2009) Curr Drug Metab, 10, pp. 459-469
dc.descriptionLaniado-Laborín, R., Cabrales-Vargas, M.N., Amphotericin B: side effects and toxicity (2009) Rev Iberoam Micol, 26, pp. 223-227
dc.descriptionRüping, M.J., Vehreschild, J.J., Cornely, O.A., Antifungal treatment strategies in high risk patients (2008) Mycoses, 51 (SUPPL. 2), pp. 46-51
dc.descriptionWingard, J.R., White, M.H., Anaissie, E., A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group (2000) Clin Infect Dis, 31, pp. 1155-1163
dc.descriptionSafdar, A., Ma, J., Saliba, F., Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis (2010) Medicine (Baltimore), 89, pp. 236-244
dc.descriptionGroll, A.H., Walsh, T.J., Uncommon opportunistic fungi: new nosocomial threats (2001) Clin Microbiol Infect, 7 (SUPPL. 2), pp. 8-24
dc.descriptionPappas, P.G., Invasive candidiasis (2006) Infect Dis Clin N Am, 20, pp. 485-506
dc.descriptionMaertens, J.A., History of the development of azole derivatives (2004) Clin Microbiol Infect, 10 (SUPPL. 1), pp. 1-10
dc.descriptionComo, J.A., Dismukes, W.E., Oral azole drugs as systemic antifungal therapy (1994) N Engl J Med, 330, pp. 263-272
dc.descriptionHeeres, J., Meerpoel, L., Lewi, P., Conazoles (2010) Molecules, 15, pp. 4129-4188
dc.descriptionAperis, G., Mylonakis, E., Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations (2006) Expert Opin Invest Drugs, 15, pp. 579-602
dc.descriptionPfaller, M.A., Espinel-Ingroff, A., Boyken, L., Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values (2011) J Clin Microbiol, 49, pp. 845-850
dc.descriptionArendrup, M.C., Epidemiology of invasive candidiasis (2010) Curr Opin Crit Care, 16, pp. 445-452
dc.descriptionWheat, J., Sarosi, G., McKinsey, D., Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America (2000) Clin Infect Dis, 30, pp. 688-695
dc.descriptionShikanai-Yasuda, M.A., Telles Filho Fde, Q., Mendes, R.P., Colombo, A.L., Moretti, M.L., Guidelines in paracoccidioidomycosis (2006) Rev Soc Bras Med Trop, 39, pp. 297-310
dc.descriptionDe Sarro, A., La Camera, E., Fera, M.T., New and investigational triazole agents for the treatment of invasive fungal infections (2008) J Chemother, 20, pp. 661-671
dc.descriptionCharlier, C., Hart, E., Lefort, A., Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? (2006) J Antimicrob Chemother, 57, pp. 384-410
dc.descriptionGoa, K.L., Barradell, L.B., Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients (1995) Drugs, 50, pp. 658-690
dc.descriptionScott, L.J., Simpson, D., Voriconazole: a review of its use in the management of invasive fungal infections (2007) Drugs, 67, pp. 269-298
dc.descriptionWalsh, T.J., Anaissie, E.J., Denning, D.W., Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America (2008) Clin Infect Dis, 46, pp. 327-360
dc.descriptionKullberg, B.J., Sobel, J.D., Ruhnke, M., Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomized non-inferiority trial (2005) Lancet, 366, pp. 1435-1442
dc.descriptionMehta, A.K., Langston, A.A., Use of posaconazole in the treatment of invasive fungal infections (2009) Expert Rev Hematol, 2, pp. 619-630
dc.descriptionSucher, A.J., Chahine, E.B., Balcer, H.E., Echinocandins: the newest class of antifungals (2009) Ann Pharmacother, 43, pp. 1647-1657
dc.descriptionHope, W.W., Shoham, S., Walsh, T.J., The pharmacology and clinical use of caspofungin (2007) Expert Opin Drug Metab Toxicol, 3, pp. 263-274
dc.descriptionFisher, B.T., Zaoutis, T., Caspofungin for the treatment of pediatric fungal infections (2008) Pediatr Infect Dis J, 27, pp. 1099-1102
dc.descriptionGarnock-Jones, K.P., Keam, S.J., Caspofungin: in pediatric patients with fungal infections (2009) Paediatr Drugs, 11, pp. 259-269
dc.descriptionLehrnbecher, T., Groll, A.H., Micafungin: a brief review of pharmacology, safety, and antifungal efficacy in pediatric patients (2010) Pediatr Blood Cancer, 55, pp. 229-232
dc.descriptionMenichetti, F., Anidulafungin, a new echinocandin: effectiveness and tolerability (2009) Drugs, 69 (SUPPL. 1), pp. 95-97
dc.descriptionPappas, P.G., Rotstein, C.M., Betts, R.F., Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (2007) Clin Infect Dis, 45, pp. 883-893
dc.descriptionTemesgen, Z., Barreto, J., Vento, S., Micafungin - the newest echinocandin (2009) Drugs Today (Barc), 45, pp. 469-478
dc.descriptionThe periodic health examination (1979) Can Med Assoc J, 121, pp. 1193-1254. , Canadian Task Force on the Periodic Health Examination
dc.descriptionVazquez, J.A., Sobel, J.D., Mucosal candidiasis (2002) Infect Dis Clin N Am, 16, pp. 793-820
dc.descriptionWeerasuriya, N., Snape, J., A study of Candida esophagitis in elderly patients attending a district general hospital in the UK (2006) Dis Esophagus, 19, pp. 189-192
dc.descriptionSugar, A.M., Oroesophageal candidiasis (2004) AIDS Read, 14, p. 572
dc.descriptionVazquez, J.A., Invasive oroesophageal candidiasis: current and developing treatment options (2003) Drugs, 63, pp. 971-989
dc.descriptionGoldman, M., Cloud, G.A., Wade, K.D., A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40 (2005) Clin Infect Dis, 41, pp. 1473-1480
dc.descriptionUnderwood, J.A., Williams, J.W., Keate, R.F., Clinical findings and risk factors for Candida esophagitis in outpatients (2003) Dis Esophagus, 16, pp. 66-69
dc.descriptionEllepola, A.N., Samaranayake, L.P., Oral candidal infections and antimycotics (2000) Crit Rev Oral Biol Med, 11, pp. 172-198
dc.descriptionGolub, J.S., Johns, M.M., Esophageal candidiasis (2005) Ear Nose Throat J, 84, p. 765
dc.descriptionCha, R., Sobel, J.D., Fluconazole for the treatment of candidiasis: 15 years experience (2004) Expert Rev Anti Infect Ther, 2, pp. 357-366
dc.relationBrazilian Journal of Infectious Diseases
dc.rightsfechado
dc.sourceScopus
dc.titleBrazilian Guidelines For The Management Of Candidiasis - A Joint Meeting Report Of Three Medical Societies: Sociedade Brasileira De Infectologia, Sociedade Paulista De Infectologia And Sociedade Brasileira De Medicina Tropical
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución